Evidence map›Paper›PMID 36282834›Full record

Trial reportPloS one2022

Strengthening patients' triage in community pharmacies: A cluster randomised controlled trial to evaluate the clinical impact of a minor ailment service.

Noelia Amador-Fernández, Shalom I Benrimoj, Antonio Olry de Labry Lima, Victoria García-Cárdenas, Miguel Ángel Gastelurrutia, Jérôme Berger, Vicente J Baixauli-Fernández, María Teresa Climent-Catalá, Vicente Colomer-Molina, Fernando Martínez-Martínez

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Development of self-care in Spanish community pharmacies.Exploratory research in clinical and social pharmacy · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Noelia Amador-FernándezCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-6491-1984
Shalom I BenrimojPharmaceutical Care Research Group, University of Granada, Granada, Spain.
Antonio Olry de Labry LimaAndalusian School of Public Health, Granada, Spain.
Victoria García-CárdenasGraduate School of Health, University of Technology Sydney, Sydney, Australia.
Miguel Ángel GastelurrutiaPharmaceutical Care Research Group, University of Granada, Granada, Spain.
Jérôme BergerCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Vicente J Baixauli-FernándezSpanish Society of Clinical, Family and Community Pharmacy, Madrid, Spain.
María Teresa Climent-CataláSpanish Society of Clinical, Family and Community Pharmacy, Madrid, Spain.
Vicente Colomer-MolinaPharmaceutical Association of Valencia, Valencia, Spain.
Fernando Martínez-MartínezPharmaceutical Care Research Group, University of Granada, Granada, Spain.
Universidad de Granada · ESSpanish Society of Family and Community Medicine · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESUniversity of Geneva · CHUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSelf-perceived minor ailments might conceal other health conditions if patients are not appropriately assisted by health care professionals. The aim of the study was to evaluate the patient-related outcomes of a community pharmacy Minor Ailment Service (MAS) compared to usual pharmacist care (UC).

methodsA cluster randomised controlled trial was conducted over six months in community pharmacy in the province of Valencia (Spain). Patients seeking care or requesting a product for a minor ailments considered in the study (dermatological problems, gastrointestinal disturbance, pain and upper respiratory tract related symptoms) were included. The intervention consisted of a standardised pharmacist-patient consultation guided by a web-based program using co-developed management protocols and patients' educational material. Patients were followed up by phone ten days later. Primary clinical outcomes were appropriate medical referral and modification of direct product request. Secondary outcomes were symptom resolution and reconsultation rates.

resultsA total of 808 patients (323 MAS and 485 UC) were recruited in 27 pharmacies of 21 municipalities. Patients visiting MAS pharmacies had higher odds for being referred to a physician (OR = 2.343, CI95% = [1.146-4.792]) and higher reconsultation rates (OR = 1.833, CI95% = [1.151-2.919]) compared to UC. No significant differences between groups were observed for modification of direct product request and symptom resolution.

conclusionsThe use of management protocols through the MAS strengthened the identification of referral criteria such as red flags in patients suffering minor ailments. These patients with symptoms of minor ailments possibly due to more severe illness were to be referred and evaluated by physicians. Results reinforce that MAS increases safety for those patients consulting in community pharmacy for minor ailments.

trial registrationTrial registration number: ISRCTN17235323. Retrospectively registered 07/05/2021, https://www.isrctn.com/ISRCTN17235323.

Indexed as

Community Pharmacy ServicesPharmaciesHumansPharmacistsReferral and ConsultationTriage

Identifiers

PMID36282834
PMCPMC9595556
OpenAlexW4307216191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.